Chest, Vol 83, 82-86, Copyright © 1983 by American College of Chest Physicians

ARTICLES

Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it

G Singh, SL Katyal, CW Bedrossian and RM Rogers

Formalin fixed paraffin-embedded lung tissues (n = 13) or lavage material (n = 4) from 17 patients in whom alveolar proteinosis was the primary disease and ten patients with other primary diagnoses but lung morphology similar to alveolar proteinosis were examined. The tissues were stained by the periodic acid-Schiff method and by the immunoperoxidase method for surfactant specific apoprotein. The intra- alveolar material in patients with primary alveolar proteinosis stained uniformly for surfactant specific apoprotein, whereas the staining was focal in patients with other primary diseases associated with intra- alveolar accumulation of proteinacious material. In both situations, the number of inflammatory cells, especially macrophages, was small. These observations extend an earlier impression about the presence of surfactant specific apoprotein in alveolar spaces in patients with primary alveolar proteinosis and provide a distinction between primary alveolar proteinosis and morphologically similar appearance due to other causes, ie, secondary alveolar proteinosis. The lack of macrophages in the affected tissue appears to be the major pathogenetic factor in alveolar proteinosis.

This article has been cited by other articles:

				J. F. Seymour and J. J. Presneill Pulmonary Alveolar Proteinosis: Progress in the First 44 Years Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 215 - 235. [Abstract] [Full Text] [PDF]

				E. Mildenberger, D. E. deMello, Z. Lin, H. Kossel, T. Hoehn, and H. T. Versmold Focal Congenital Alveolar Proteinosis Associated With Abnormal Surfactant Protein B Messenger RNA Chest, February 1, 2001; 119(2): 645 - 647. [Abstract] [Full Text] [PDF]

				P. L Shah, D. Hansell, P. R Lawson, K. B M Reid, and C. Morgan Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis Thorax, January 1, 2000; 55(1): 67 - 77. [Full Text]

				T. TAKAHASHI, M. MUNAKATA, I. SUZUKI, and Y. KAWAKAMI Serum and Bronchoalveolar Fluid KL-6 Levels in Patients with Pulmonary Alveolar Proteinosis Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1294 - 1298. [Abstract] [Full Text] [PDF]

				M. Nakajima, T. Manabe, Y. Niki, and T. Matsushima Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax, September 1, 1998; 53(9): 809 - 811. [Abstract] [Full Text]

				D. J. Beer and E. J. Mark Case 22-1994- A 57-Year-Old Man with a Chronic Productive Cough, Dyspnea, and Extensive Bilateral Air-Space Disease N. Engl. J. Med., June 2, 1994; 330(22): 1599 - 1606. [Full Text]